(2S,5S,2'S,5'S)-Dihydroxylysinonorleucine
CAS: 32619-23-1
Ref. 3D-FD22117
| 25µg | Descontinuado | ||
| 50µg | Descontinuado | ||
| 100µg | Descontinuado | ||
| 250µg | Descontinuado | ||
| 500µg | Descontinuado |
Informação sobre produto
Nome:
(2S,5S,2'S,5'S)-Dihydroxylysinonorleucine
Sinónimos:
- N6-[(2S,5S)-5-amino-5-carboxy-2-hydroxypentyl]-5-hydroxy-L-lysine(5S,5'S)-Hydroxylysinohydroxynorleucine
- L-Lysine,N6-(5-amino-5-carboxy-2-hydroxypentyl)-5-hydroxy-, erythro-
- Norleucine,6,6'-iminobis[5-hydroxy-, L- (8CI)
- Dhlnl
- Hydroxylysinohydroxynorleucine
- Reduced syndesine
- d,d'-Dihydroxylysinonorleucine
Descrição:
L-Lysine is a non-essential amino acid that is found in animal proteins such as dairy and eggs. It is used for the treatment of proliferative diabetic retinopathy, which is a complication of diabetes. L-Lysine inhibits the enzyme lysyl oxidase, which crosslinks collagen molecules to form mature collagen fibers. This leads to structural changes in the eye, causing a reduction in neovascularization and prevention of blindness. Chronic exposure to L-lysine has been shown to cause biochemical abnormalities including an increase in creatinine levels and decreased levels of albumin. However, there are no known adverse effects on hematopoietic cells or inflammatory diseases due to L-lysine therapy.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
307.34 g/mol
Fórmula:
C12H25N3O6
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
